Stock Events

Stock Events

NewAmsterdam Pharma Company NV (NAMS) Q3 2025 Earnings

6AugConfirmed

Q4 2024

Q1 2025

Q2 2025

Q3 2025

-0.93

-0.67

-0.41

-0.15

Details

Expected EPS

-0.463166

Actual EPS

-0.15

Surprise EPS

0.31

Surprise Percent

+67.61%

Description

NewAmsterdam Pharma Company NV (NAMS) has reported earnings of -0.15 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.